GEN Exclusives

More »

GEN News Highlights

More »
Jun 20, 2013

Sanofi, Curie-Cancer Partner on Ovarian Cancer Drug Discovery, Development

  • Sanofi and the Curie Institute are teaming up as part of a three-year preclinical research collaboration to discovery and development of new therapeutic targets for ovarian cancer.

    Participating through its Institut Carnot arm, Curie-Cancer is working with Sanofi to “revisit the basic biology of this type of cancer through a translational research approach,” the partners said. Financial terms were not disclosed.

    Sanofi will provide its expertise in the selection of therapeutic targets. For its part, the Curie Institute offers a large collection of cryopreserved tumor samples, which are characterized clinically, histologically, and biologically. Together, the organizations hope to better understand the molecular alterations behind ovarian cancers, and design drugs to better target those.

    "We hope this type of long-term collaboration will ultimately open up perspectives for new therapeutic options for women with this disease. It will combine the accumulated knowledge on ovarian cancer gathered over many years by oncologists and biologists at the Institut Curie with the expertise of researchers from Sanofi’s research and product development teams," Debasish Roychowdhury, M.D., svp and head, Sanofi Oncology, said in a statement. "Established under the Aviesan1 partnership, this research agreement is a good example of translational research involving French scientific excellence.”

    Added Curie-Cancer Director Damien Salauze: “To potentially provide our patients with additional therapeutic solutions, we are very happy to collaborate with Sanofi, whose expertise in the selection of therapeutic targets is complementary to the know-how and technology platforms developed at the Institut Curie.”

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »